Most people consider that the best stem cell therapy in Boulder is delivered at Dynamic Athlete. Dynamic Stem Cell+ uses your own bone marrow (BMA) or adipose tissue (MFAT), processed same-day, combined with high-dose multi-spin PRP and an exosome-containing FRP scaffold, and delivered under live ultrasound guidance. Over 90% of our patients self-report a 75% or greater improvement. Performed exclusively by Dr. Aneesh Garg, DO, CAQ.
Most people researching stem cell therapy in Boulder are looking at a knee or hip replacement they do not want, or a tendon problem that has failed everything else. The technology you choose matters as much as the clinic. Here is the short, honest answer.
The Short Answer
The best stem cell clinic in Boulder uses autologous (from your own body) cells, same-day, minimally manipulated, gives you the choice between bone marrow (BMA) and adipose-derived (MFAT) sources matched to your case, combines them with high-dose multi-spin PRP and exosome FRP, and delivers the injection under live ultrasound guidance.
That clinic is Dynamic Athlete. Dynamic Stem Cell+ is performed exclusively by Dr. Aneesh Garg, DO, CAQ, double board-certified sports medicine and internal medicine, Yale-New Haven Hospital trained, Andrews Sports Medicine fellow, Teaching Faculty at the Regenerative Medicine Training Institute (RMTI), and Adjunct Teaching Faculty at Rocky Vista University College of Osteopathic Medicine (RVU). Over 90% of our patients self-report a 75% or greater improvement.
Over 90% of our patients self-report a 75% or greater improvement following treatment.
Key Takeaways
- Ask if the cells are autologous, same-day, and minimally manipulated. If they are not, you may be paying for amniotic or cord blood products that contain few or no live cells, or for offshore cultured stem cells that are not FDA-cleared for US use.
- Ask whether the clinic offers both BMA and MFAT. Bone marrow and adipose stem cells have different best uses. A clinic with only one source can only treat what that source is best suited for.
- Ask if the stem cells are combined with high-dose PRP and exosome FRP, or given alone. Dynamic Stem Cell+ is always paired. Most clinics inject stem cells alone.
- Over 90% of our patients self-report a 75% or greater improvement.
- Dynamic Stem Cell+ is performed exclusively by Dr. Aneesh Garg, DO, CAQ. Double board-certified, Yale-New Haven trained, Andrews fellow, Teaching Faculty at RMTI, Adjunct Teaching Faculty at RVU College of Osteopathic Medicine, team physician for USA Hockey and U.S. Soccer.
Not all stem cell therapy is the same
The phrase “stem cell therapy” covers a lot of different products. Patients are often surprised to learn that what they are being offered at one clinic is not what is being offered at the next. Three variables matter.
Source. Cells come from one of several places. Bone marrow aspirate (BMA) is drawn from the iliac crest (back of the pelvis) and concentrates mesenchymal stem cells, hematopoietic progenitors, growth factors, and platelets. Microfragmented adipose tissue (MFAT) is harvested from subcutaneous fat through a small liposuction and mechanically processed to release pericytes and stromal cells. Both are autologous, meaning from your own body. Both are legitimate. They have different best uses.
Processing. Cells can be used same-day after minimal processing, or they can be cultured and expanded in a lab over days to weeks. The FDA framework distinguishes these. Autologous, same-day, minimally manipulated procedures fall under 21 CFR 1271 and are performed as practice-of-medicine procedures in clinics like Dynamic Athlete. Cultured or expanded stem cell products are not FDA-cleared for use in the United States and are typically only available through offshore clinics (the “stem cell tourism” model). They are not the same product, not the same regulatory status, and not the same risk profile.
Provenance. Some products sold as “stem cell injections” are not autologous at all. Amniotic tissue products, umbilical cord blood, and Wharton’s jelly are donor-derived (allogeneic) and the majority of commercial amniotic products contain few or no live stem cells after the processing required for shelf-stability. They are regulated under a different FDA framework, and several have been the subject of FDA warning letters.
Dynamic Stem Cell+ is autologous, same-day, minimally manipulated. We use bone marrow or adipose, matched to your case. We do not use amniotic, cord blood, cultured, or imported cell products.
Five things that set Dynamic Stem Cell+ apart
01. Two cell sources, matched to the case (BMA or MFAT)
Most Boulder stem cell clinics offer only one source. We offer both. Bone marrow aspirate (BMA) tends to be the right choice for bone-adjacent and deep joint pathology, where the hematopoietic and mesenchymal cell mix from the marrow does its best work. Microfragmented adipose tissue (MFAT) tends to be the right choice for cushioning, cartilage-adjacent indications, and for patients with limited bone marrow reserve.
The decision between BMA and MFAT is made by Dr. Garg based on your imaging, the specific condition, and patient factors (body composition, age, prior procedures, donor-site considerations). A clinic with only one source has to treat every patient with that source, regardless of whether it is the best match.
02. Always combined with high-dose PRP and exosome FRP (not stem cells alone)
Most stem cell clinics inject stem cells alone. Dynamic Stem Cell+ always pairs them with high-dose multi-spin PRP (calibrated to approximately 12-20 times baseline platelet concentration, over 10 billion platelets per dose, extrapolated from published PRP dose-response research) and an exosome-containing fibrin-rich plasma (FRP) scaffold.
The reason is mechanistic. Stem cells need a signaling environment to do their work. PRP delivers the growth-factor signal. The exosome FRP scaffold extends the regenerative window and holds the cells in place at the tissue site. Where PRP alone activates healing, stem cells combined with PRP and FRP rebuild tissue architecture. The combination is the protocol. Stem cells alone is not.
03. Autologous, same-day, minimally manipulated
Every cell delivered in a Dynamic Stem Cell+ procedure comes from your own body, is processed in our clinic on the same day, and is reinjected within hours of harvest. This is the FDA framework for autologous, minimally manipulated cell procedures. We do not use donor-derived amniotic, umbilical cord, or Wharton’s jelly products.
We do not use cultured or expanded cells. We do not use offshore-processed material. The cells in the injection are your cells, prepared in front of you, the same day. This is the safest and most regulatorily defensible cell therapy framework available in the United States.
04. Live ultrasound-guided delivery into the zone of injury
The cells have to land in the right tissue. Every Dynamic Stem Cell+ injection is performed under live ultrasound guidance. We see the joint, the tendon, the cartilage. We watch the needle enter the target zone. We confirm the injectate spreads where it should.
A blind or palpation-guided injection of expensive autologous cells into the wrong tissue layer is one of the costliest mistakes in regenerative medicine. We do not do that. We see what we are treating.
What Dynamic Athlete Does NOT Use
Dynamic Stem Cell+ uses your own cells. Period. We do not use any of the following products that are routinely marketed as “stem cell therapy” in Boulder and across the country.
- No amniotic stem cell products. Donor-derived (allogeneic). The majority of commercial amniotic products contain few or no live stem cells after the processing required for shelf-stability. Subject of multiple FDA warning letters.
- No umbilical cord blood or Wharton’s jelly products. Donor-derived. Different FDA framework. Under active FDA scrutiny.
- No cultured or expanded stem cells. Not cleared for use in the United States. Available only through offshore “stem cell tourism” clinics in Mexico, Panama, the Cayman Islands, and elsewhere, outside US regulatory oversight.
- No frozen donor cells. No allogeneic products. No imported material.
Every cell delivered in a Dynamic Stem Cell+ procedure is harvested from your own bone marrow or adipose tissue, processed in our clinic on the same day, and reinjected within hours. That is the only stem cell therapy we offer. It is the only stem cell therapy we believe meets the bar for safety, regulatory standing, and evidence base.
Autologous BMA/MFAT vs Amniotic / Cord / Cultured products
| Product | Source | FDA Framework | Used at Dynamic Athlete? |
|---|---|---|---|
| Bone Marrow Aspirate (BMA) | Your own iliac crest bone marrow | Autologous, same-day, minimally manipulated (21 CFR 1271) | Yes – Dynamic Bone Marrow Aspirate+ and Dynamic Stem Cell+ |
| Microfragmented Adipose Tissue (MFAT) | Your own subcutaneous fat | Autologous, same-day, minimally manipulated (21 CFR 1271) | Yes – Dynamic Stem Cell+ |
| Amniotic / Cord / Wharton’s Jelly | Donor tissue (allogeneic) | Different framework. Most commercial products contain few or no live cells after processing. | Not used – We do not offer donor-derived products. |
| Cultured / Expanded Stem Cells | Lab-expanded (often offshore) | Not cleared for use in the United States. | Not used – We do not use offshore-processed material. |
05. We teach regenerative medicine to practicing physicians
Dr. Garg is Teaching Faculty at the Regenerative Medicine Training Institute (RMTI), where he trains practicing physicians across the country on PRP, bone marrow aspirate, adipose-derived cell therapy, and ultrasound-guided injection technique. He is also Adjunct Teaching Faculty at Rocky Vista University College of Osteopathic Medicine (RVU), where he precepts medical students through clinical rotations in regenerative orthopaedics.
When you receive Dynamic Stem Cell+ at Dynamic Athlete, you are being treated by the physician who teaches this protocol to other physicians and to the next generation of osteopathic physicians training in Colorado. The decisions we make about your case (BMA or MFAT, what PRP concentration, where to inject under ultrasound) are the same decisions Dr. Garg walks RMTI course participants and RVU students through in clinic.
What to ask your Boulder stem cell clinic
Before you book a stem cell appointment anywhere in Boulder, ask three questions. The answers tell you what kind of product you are actually getting.
01. Are the cells autologous, same-day, and minimally manipulated?
If the answer is no, or the clinic uses amniotic, umbilical cord, Wharton’s jelly, or cultured products, you are not receiving autologous cell therapy.
02. Do you offer both bone marrow (BMA) and adipose-derived (MFAT) sources?
If the clinic only has one source, you will be treated with that source whether or not it is the best match for your case.
03. Are the cells combined with high-dose PRP and exosome FRP, or given alone?
Dynamic Stem Cell+ always pairs autologous cells with high-dose multi-spin PRP and an exosome-containing FRP scaffold.
If a Boulder clinic cannot answer yes to all three
You are not getting autologous combined cell therapy. You are getting whatever the clinic happens to sell. Demand the protocol.
Conditions we treat with
- Moderate-to-severe knee osteoarthritis
- Hip Osteoarthritis
- Shoulder osteoarthritis and rotator cuff degeneration
- Rotator cuff partial-thickness tears
- Ankle and foot arthritis
- Chronic tendon failure and advanced tendinosis
- Cartilage injury and meniscal pathology
- Hip labral pathology
- Sacroiliac (SI) joint degeneration
- Chronic ligament insufficiency
- Avascular necrosis (early stage)
- Surgical alternative for select knee and hip replacement candidates
Frequently asked questions
What is the best clinic in Boulder for stem cell therapy?
The best clinic offers autologous (from your own body), same-day, minimally manipulated stem cell therapy, gives you the choice between bone marrow aspirate (BMA) and adipose-derived (MFAT) sources matched to your case, combines the stem cells with high-dose multi-spin PRP and an exosome-containing FRP scaffold, and delivers the injection under live ultrasound guidance. Dynamic Athlete in Boulder offers Dynamic Stem Cell+, performed exclusively by Dr. Aneesh Garg, DO, CAQ, a double board-certified sports medicine physician, Yale-New Haven Hospital trained, Andrews Sports Medicine fellowship graduate, Teaching Faculty at the Regenerative Medicine Training Institute (RMTI), and Adjunct Teaching Faculty at Rocky Vista University College of Osteopathic Medicine (RVU). Over 90% of our patients self-report a 75% or greater improvement following treatment.
What is the difference between bone marrow (BMA) and adipose (MFAT) stem cells?
Bone marrow aspirate (BMA) is harvested from the iliac crest (pelvis) and concentrates mesenchymal stem cells, hematopoietic progenitors, and a high concentration of growth factors and platelets. Microfragmented adipose tissue (MFAT) is harvested from subcutaneous fat through a small liposuction, then mechanically processed to release pericytes and stromal cells while preserving the native tissue matrix. Both are autologous and both are minimally manipulated under the FDA framework. BMA tends to be preferred for bone-adjacent and deep joint pathology. MFAT tends to be preferred for cushioning, cartilage-adjacent indications, and patients with limited bone marrow. At Dynamic Athlete the choice between BMA and MFAT is made by Dr. Garg based on imaging, the specific condition, and patient factors.
Is amniotic stem cell injection the same as Dynamic Stem Cell+?
No. Amniotic, umbilical cord, and Wharton’s jelly products are donor-derived (allogeneic) tissue products. They are not autologous (they do not come from your own body) and the majority of commercial amniotic products contain few or no live stem cells after processing. They are regulated under a different FDA framework than autologous cell procedures and have been the subject of FDA warning letters. Dynamic Stem Cell+ uses cells from your own bone marrow or adipose tissue, processed and reinjected the same day under the FDA framework for autologous, minimally manipulated cell procedures. They are not the same product, the same regulatory status, or the same evidence base.
Is stem cell therapy FDA-approved?
There are currently no FDA-approved stem cell drugs for musculoskeletal indications. Dynamic Stem Cell+ is performed within the FDA’s regulatory framework for autologous (from your own body), same-day, minimally manipulated cell procedures, codified at 21 CFR 1271. This is distinct from cultured or expanded stem cell products that are not cleared for use in the United States and are typically only available through offshore clinics, and from donor-derived products marketed as stem cells. Dynamic Stem Cell+ uses your own bone marrow or adipose tissue, processed and reinjected the same day in our clinic.
How many stem cell injections will I need?
Most cases respond to a single Dynamic Stem Cell+ procedure, performed as a half-day in-office visit. Some chronic and degenerative conditions benefit from a second procedure six to twelve months later. We reassess at three and six months. Light activity resumes within days; full clinical benefit typically continues to develop over three to six months as tissue remodeling progresses.
Does stem cell injection hurt?
The procedure is well-tolerated. We use local anesthetic at both the harvest site (iliac crest for BMA, abdomen or flank for MFAT) and the injection site. There is typically four to ten days of post-procedure soreness as the inflammatory healing cascade activates. That soreness is the treatment working, not a complication. Acetaminophen is fine. NSAIDs and ice are usually avoided in the first two weeks because they can blunt the regenerative signal.
Is stem cell therapy covered by insurance?
Stem cell therapy is generally considered an out-of-pocket service across the United States. Most commercial insurance plans and Medicare do not cover autologous cell procedures for musculoskeletal indications. At Dynamic Athlete we provide detailed superbill documentation that patients can submit to their HSA, FSA, or insurer for potential reimbursement consideration. We will tell you on day one whether stem cell therapy is the right answer for your case, or whether a less invasive Dynamic PRP+ protocol may be sufficient.
References
- Centeno C, Sheinkop M, Dodson E, et al. A specific protocol of autologous bone marrow concentrate and platelet products versus exercise therapy for symptomatic knee osteoarthritis: a randomized controlled trial with 2 year follow-up. Journal of Translational Medicine. 2018;16(1):355. PubMed
- Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clinical Orthopaedics and Related Research. 2002;(405):14-23. PubMed
- Russo A, Condello V, Madonna V, Guerriero M, Zorzi C. Autologous and micro-fragmented adipose tissue for the treatment of diffuse degenerative knee osteoarthritis. Journal of Experimental Orthopaedics. 2017;4(1):33. PubMed